Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs WCC✓SelectedUSD · WCCGSK vs WCC performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs WCC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
WCC return
+111.7%
Excess return
-70.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioWCCExcessAlpha
1D-0.1%-8.2%+8.1%+0.2%
7D-5.3%-12.4%+7.0%-4.8%
30D-3.7%-19.2%+15.5%-3.0%
3M-7.3%-16.5%+9.2%-6.9%
6M-4.2%-19.2%+14.9%-3.9%
YTD+0.9%+15.8%-15.0%-1.3%
1Y+7.3%+14.9%-7.7%+5.0%
3Y+52.7%+88.8%-36.1%+41.8%
All+41.1%+111.7%-70.6%+24.8%

Cumulative growth

Daily Returns

Daily percentage return beside WCC.

Daily Out/Under-Performance

Portfolio return minus WCC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × WCC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded WCC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling